{
  "spec_version": "4",
  "endpoint": "financials-segment",
  "stock_code": "3151",
  "company_name": "バイタルケーエスケー・ホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/3151/current/#revenue-mix",
  "api_url": "/api/3151/financials/segment.json",
  "updated": "2026-09-19",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/3151/current/#revenue-mix",
  "source": {
    "segment": {
      "primary": [
        "有価証券報告書（セグメント情報）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
    },
    "region": {
      "primary": [
        "有価証券報告書（所在地別・海外売上高）"
      ],
      "extraction": "EDINET の XBRL から機械抽出",
      "caveat": "地域区分は各期の開示区分をそのまま採録している"
    }
  },
  "html_url": "https://the-shashi.com/tse/3151/current/#revenue-mix",
  "segment": [
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 591867,
      "profit": 6532,
      "assets": 313346
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 552283,
      "profit": 3034,
      "assets": 287430
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 536839,
      "profit": 2073,
      "assets": 302932
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 531400,
      "profit": 2639,
      "assets": 311813
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "動物用医薬品卸売事業",
      "sales": 9713,
      "profit": 353,
      "assets": 4573
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 533412,
      "profit": 3164,
      "assets": 290118
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "動物用医薬品卸売事業",
      "sales": 9811,
      "profit": 401,
      "assets": 4736
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 506389,
      "profit": -2542,
      "assets": 293917
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬局事業",
      "sales": 16772,
      "profit": -19,
      "assets": 9763
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "動物用医薬品卸売事業",
      "sales": 10399,
      "profit": 371,
      "assets": 5186
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 544249,
      "profit": 2443,
      "assets": 295496
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬局事業",
      "sales": 18397,
      "profit": 205,
      "assets": 10610
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "動物用医薬品卸売事業",
      "sales": 10889,
      "profit": 349,
      "assets": 5288
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 547603,
      "profit": 3597,
      "assets": 281594
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬局事業",
      "sales": 18361,
      "profit": 106,
      "assets": 8794
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "動物用医薬品卸売事業",
      "sales": 11027,
      "profit": 350,
      "assets": 5431
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 552870,
      "profit": 4913,
      "assets": 297526
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬局事業",
      "sales": 19115,
      "profit": 310,
      "assets": 9502
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "動物用医薬品卸売事業",
      "sales": 11626,
      "profit": 314,
      "assets": 5795
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 564614,
      "profit": 5163,
      "assets": 279356
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬局事業",
      "sales": 19552,
      "profit": 251,
      "assets": 9380
    }
  ],
  "region": [
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "region": null,
      "sales": null
    }
  ]
}